AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

20 recruiting trials

for Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

PROCARE - PROstate Cancer Real World Evidence Registry NCT06835218n/a53 sites๐Ÿ“ Freiburg im Breisgau๐Ÿ“ Heidelberg๐Ÿ“ Mannheim UroTrials Company (GmbH) Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer NCT07140900Phase 116 sites๐Ÿ“ San Francisco๐Ÿ“ Boston๐Ÿ“ Minneapolis Amgen ยท Tests: Xaluritamig, Darolutamide, Abiraterone Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer NCT07216248Phase 21 site๐Ÿ“ Salt Lake City University of Utah ยท Tests: relugolix + ARPI, Intermittent- Relugolix or androgen deprivation therapy (ADT) + ARPI, relugolix or androgen deprivatiโ€ฆ A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer NCT07241416Phase 31 site๐Ÿ“ Beijing Jiangsu HengRui Medicine Co., Ltd. ยท Tests: Rezvilutamide Tablets, Enzalutamide Soft Capsules Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients NCT06350825Phase 31 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Cytoreductive prostatectomy or brachytherapy, ADT+second-generation antiandrogens ยฑ chemotherapy A Study to Assess Adherence to Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer Participants in France NCT07451002n/a1 site๐Ÿ“ Caen Janssen Cilag S.A.S. How Darolutamide Plus Hormone Therapy Works for Men With Advanced Prostate Cancer in Everyday Medical Practice in Germany NCT07395804n/a1 site๐Ÿ“ Locations Bayer ยท Tests: darolutamide plus ADT treatment Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial NCT07650240Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Abiraterone Acetate, Biospecimen Collection, Leuprolide Acetate, Lutetium Lu 177 Vipivotide Tetraxetan, Prednisone Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC NCT07172685NA1 site๐Ÿ“ Jinan Qilu Hospital of Shandong University ยท Tests: Darolutamide , Docetaxel , ADT and Transrectal HIFU Focal Therapy ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer NCT03903835Phase 332 sites๐Ÿ“ Aalst๐Ÿ“ Antwerp๐Ÿ“ Bruges Karolinska Institutet ยท Tests: Enzalutamide Oral Capsule, Abiraterone Oral Tablet, Carboplatin, Cabazitaxel 60 mg Solution for Injection, Docetaxel Inโ€ฆ TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) NCT07190300Phase 1, Phase 231 sites๐Ÿ“ Birmingham๐Ÿ“ Iowa City๐Ÿ“ Westwood Novartis Pharmaceuticals ยท Tests: Tulmimetostat, Darolutamide, Abiraterone, Prednisone/Prednisolone, Androgen Deprivation Therapy (ADT) A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer NCT06661122n/a1 site๐Ÿ“ Multiple Locations Bayer ยท Tests: Darolutamide (BAY1841788) + docetaxel + ADT Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC NCT05983783Phase 31 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Docetaxel, Rezvilutamide Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC NCT06177015Phase 31 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Darolutamide continuous, Darolutamide intermittent Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA โ‰ฅ 0.2 ng/mL (EvoPAR-PR05) NCT07711002Phase 3210 sites๐Ÿ“ Hot Springs๐Ÿ“ Springdale๐Ÿ“ Beverly Hills AstraZeneca ยท Tests: Saruparib, Placebo, Enzalutamide, Darolutamide, Abiraterone Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC NCT05956639Phase 31 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: 6-month course of antiandrogen drugs, Long-term course of antiandrogen drugs The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer NCT06446401n/a2 sites๐Ÿ“ Uppsala๐Ÿ“ Uppsala Uppsala University ยท Tests: ADT + NHT + Docetaxel, ADT + NHT Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders) NCT06496581Phase 325 sites๐Ÿ“ Angers๐Ÿ“ Bordeaux๐Ÿ“ Brest UNICANCER ยท Tests: 177Lu-PMSA-617, Standard of Care Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment NCT05649943NA3 sites๐Ÿ“ Milan๐Ÿ“ Milan๐Ÿ“ Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano ยท Tests: APA + ADT, Local Treatmetn RT or RP A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics NCT07406282n/a1 site๐Ÿ“ Cleveland Bayer ยท Tests: Darolutamide, Abiraterone acetate, Enzalutamide, Apalutamide
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy